Systemic Drugs Associated With Maculopathy
These findings suggest that the integration of pharmacovigilance signal detection and nationwide health claims analysis identified associations of maculopathy with apixaban, paclitaxel, ibrutinib, and sildenafil. This combined approach offers a potentially cost-effective, robust method for identifying systemic drugs with possibly underrecognized macular adverse effects.
Authors
- Jee Eun Chung (ORCID: https://orcid.org/0000-0001-5608-1530)
- Emily W. Gower (ORCID: https://orcid.org/0000-0003-1016-9910)
- Seong Joon Ahn (ORCID: https://orcid.org/0000-0002-4545-8344)
- Jiyeon Park (ORCID: https://orcid.org/0009-0005-6871-1081)
- Jiyeong Kim (ORCID: https://orcid.org/0000-0002-7969-1419)
Institutions
- University of North Carolina at Chapel Hill (US)
- Hanyang University Seoul Hospital (KR)
- Hanyang University (KR)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.3612
- Citations
- 2
- Primary Topic
- Drug-Induced Ocular Toxicity
- Type
- article
- Field-Weighted Citation Impact
- 3.41